MetroWest Medical Center-Framingham Union Hospital
Framingham, Massachusetts, United States
Teaching hospital in Framingham, Massachusetts
115 Lincoln St, Framingham, MA 01702
About MetroWest Medical Center-Framingham Union Hospital
MetroWest Medical Center is a teaching hospital in Framingham and Natick, Massachusetts. It is the largest health care provider in the MetroWest region between Boston and Worcester.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MetroWest Medical Center-Framingham Union Hospital
During the past decade, MetroWest Medical Center-Framingham Union Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 19 clinical trials were completed, i.e. on
average, 271.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer
2002-09-01
2016-12-01
Completed
356
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MetroWest Medical Center-Framingham Union Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Gilead Sciences" with 5 trials
sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology"
with 3 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MetroWest Medical Center-Framingham Union Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 29 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at MetroWest Medical Center-Framingham Union Hospital
According to Clinical.Site data, the most researched conditions in "MetroWest Medical Center-Framingham Union Hospital" are
"Breast Cancer" (5 trials), "Recurrent Breast Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "MetroWest Medical Center-Framingham Union Hospital" in a lesser frequency.
Clinical Trials Intervention Types at MetroWest Medical Center-Framingham Union Hospital
Most popular intervention types in "MetroWest Medical Center-Framingham Union Hospital" are "Drug" (28 trials), "Other" (17 trials), "Biological" (8 trials), "Radiation" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Placebo" (5 trials), "Paclitaxel" (4 trials), "Quality-of-Life Assessment" (4 trials) and "placebo" (4 trials). Other intervention names were less common.
Clinical Trials Genders at MetroWest Medical Center-Framingham Union Hospital
The vast majority of trials in "MetroWest Medical Center-Framingham Union Hospital" are
29 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at MetroWest Medical Center-Framingham Union Hospital
Currently, there are NaN active trials in "MetroWest Medical Center-Framingham Union Hospital".
undefined are not yet recruiting,
4 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in MetroWest Medical Center-Framingham Union Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in MetroWest Medical Center-Framingham Union Hospital, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 8 trials that are defined as “Not Applicable".